首页> 外文期刊>The Journal of biological chemistry >Structural Basis for Dual Nucleotide Selectivity of Aminoglycoside 2″-Phosphotransferase IVa Provides Insight on Determinants of Nucleotide Specificity of Aminoglycoside Kinases
【24h】

Structural Basis for Dual Nucleotide Selectivity of Aminoglycoside 2″-Phosphotransferase IVa Provides Insight on Determinants of Nucleotide Specificity of Aminoglycoside Kinases

机译:氨基糖苷2“-Phosphoseferase IVA的双核苷酸选择性的结构基础提供了对氨基糖苷类激酶的核苷酸特异性的决定因素的见解

获取原文
       

摘要

Enzymatic phosphorylation through a family of enzymes called aminoglycoside O-phosphotransferases (APHs) is a major mechanism by which bacteria confer resistance to aminoglycoside antibiotics. Members of the APH(2″) subfamily are of particular clinical interest because of their prevalence in pathogenic strains and their broad substrate spectra. APH(2″) enzymes display differential preferences between ATP or GTP as the phosphate donor, with aminoglycoside 2″-phosphotransferase IVa (APH(2″)-IVa) being a member that utilizes both nucleotides at comparable efficiencies. We report here four crystal structures of APH(2″)-IVa, two of the wild type enzyme and two of single amino acid mutants, each in complex with either adenosine or guanosine. Together, these structures afford a detailed look at the nucleoside-binding site architecture for this enzyme and reveal key elements that confer dual nucleotide specificity, including a solvent network in the interior of the nucleoside-binding pocket and the conformation of an interdomain linker loop. Steady state kinetic studies, as well as sequence and structural comparisons with members of the APH(2″) subfamily and other aminoglycoside kinases, rationalize the different substrate preferences for these enzymes. Finally, despite poor overall sequence similarity and structural homology, analysis of the nucleoside-binding pocket of APH(2″)-IVa shows a striking resemblance to that of eukaryotic casein kinase 2 (CK2), which also exhibits dual nucleotide specificity. These results, in complement with the multitude of existing inhibitors against CK2, can serve as a structural basis for the design of nucleotide-competitive inhibitors against clinically relevant APH enzymes.
机译:通过一种称为氨基糖苷O-磷酸转移酶(APHS)的酶酶酶磷酸化是细菌对氨基糖苷类抗生素的抗性的主要机制。由于其在致病菌株及其宽底物光谱中的患病率,APH(2“)亚家族的成员是特定的临床兴趣。 APH(2“)酶在ATP或GTP之间显示差异偏好,作为磷酸盐供体,氨基糖苷2” - βphosphersferaseIVA(APH(2“) - IVA)是在可比效率下使用两个核苷酸的构件。我们在此报告四种晶体结构的APH(2“) - IVA,两种野生型酶和两种单一氨基酸突变体,各自与腺苷或鸟苷一起复合。这些结构一起详细研究该酶的核苷结合位点架构,并揭示赋予双核苷酸特异性的关键元件,包括核苷结合口袋内部的溶剂网络和互联连接环的构象。稳态动力学研究,以及与APH(2“)亚家族和其他氨基糖苷类激酶成员的序列和结构比较,合理化这些酶的不同基材偏好。最后,尽管总体序列相似性和结构同源差,但APH(2“) - IVA的核苷结合袋的分析显示了与真核酪蛋白激酶2(CK2)的相似性,这也表现出双核苷酸特异性。这些结果,与CK2的众多现有抑制剂相得益彰,可以作为针对临床相关APZ酶设计的核苷酸竞争性抑制剂的结构基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号